Bing Xu
- Pharmacology top 1%
- Pharmacological Effects of Natural Compounds 9
- Berberine and alkaloids research 4
- Plant-based Medicinal Research 4
-
- Traditional Chinese Medicine Analysis 15
- Medicinal Plants and Neuroprotection 5
- Ophthalmology top 5%
- Retinal Diseases and Treatments 4
- Toxicology top 5%
- Biomaterials top 10%
-
- Natural product bioactivities and synthesis 12
- Bioactive natural compounds 6
- Journals
- SHILAP Revista de lepidopterología (2 papers)PLoS ONE (1 paper)ACS Applied Materials & Interfaces (2 papers)
In The Last Decade
Bing Xu
76 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 121
- Pharmacology 295
- Complementary and alternative medicine 179
- Ophthalmology 168
- Toxicology 52
- Biomaterials 176
Countries citing papers authored by Bing Xu
This map shows the geographic impact of Bing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Xu more than expected).
Fields of papers citing papers by Bing Xu
This network shows the impact of papers produced by Bing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Xu. The network helps show where Bing Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bing Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 15 | |
| 8 | 2023 | 5 | |
| 9 | 2022 | 4 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 30 | |
| 12 | 2021 | 25 | |
| 13 | 2020 | 2 | |
| 14 | 2019 | 156 | |
| 15 | 2019 | 28 | |
| 16 | 2017 | 31 | |
| 17 | 2015 | 16 | |
| 18 | 2015 | 74 | |
| 19 | 2011 | 41 | |
| 20 | 2010 | 33 |
About Bing Xu
Bing Xu is a scholar working on Complementary and alternative medicine, Pharmacology and Toxicology, having authored 80 papers that have together received 1.7k indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (15 papers), Natural product bioactivities and synthesis (12 papers), Pharmacological Effects of Natural Compounds (9 papers), Bioactive natural compounds (6 papers), Medicinal Plants and Neuroprotection (5 papers), Retinal Diseases and Treatments (4 papers), Berberine and alkaloids research (4 papers) and Plant-based Medicinal Research (4 papers). The work is most often cited by research in Pharmacology (295 citations), Complementary and alternative medicine (179 citations) and Ophthalmology (168 citations). Bing Xu has collaborated with scholars based in China, Hong Kong and Russia. Frequent co-authors include Haimin Lei, Liqun Chu, Ning Dong, Penglong Wang, Wenbo Guo, Penglong Wang, Desheng Cai, Xuehao Tian, Bingsong Wang and Xuemei Huang. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.